Sangamo Therapeutics Inc Stock Price. Everything You Need To Know About The Sangamo Therapeutics Inc Stock! Sangamo Therapeutics Inc Stock Price. Everything You Need To Know About The Sangamo Therapeutics Inc Stock!


Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The company is headquartered in Brisbane California, California and currently employs 478 full-time employees. The company went IPO on 2000-04-06. The firm focuses on leveraging its optimized zinc finger (ZF) technology, which is a differentiated tool used to develop genomic medicines, including allogeneic cell therapies and in vivo genome engineering therapies. Its product candidates include Isaralgagene civaparvovec, also known as ST-920, its wholly owned gene therapy product candidate for the treatment of Fabry disease; TX200, its wholly owned Chimeric Antigen Receptor (CAR), engineered regulatory T cell (CAR-Treg) cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; Giroctocogene fitelparvovec, also known as SB-525, is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A., and BIVV003, its zinc finger nuclease, or ZF nuclease, gene-edited cell therapy product candidate for the treatment of sickle cell disease (SCD).



Sangamo Therapeutics Inc Stock Price. Everything You Need To Know About The Sangamo Therapeutics Inc Stock! performance

  • Employees 478
  • Company HQ Brisbane California
  • Website https://www.sangamo.com/
  • SGMO Asset Type Common Stock
  • SGMO Market Capitalization 90.5M
  • Earnings Per Share -1.88
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Sangamo Therapeutics. As a leading biotechnology company, Sangamo Therapeutics focuses on developing genomic medicines to transform the lives of patients with genetic diseases. With its innovative approach and robust pipeline, investing in Sangamo Therapeutics can offer tremendous growth opportunities. But how can you invest in this promising stock from Malaysia, Thailand, Indonesia, or Vietnam? At Zorion, our investment platform provides you with the tools and insights you need to make informed decisions. Our resources and educational materials are tailored to help retail investors like you enhance your investment knowledge in order to invest confidently in Sangamo Therapeutics. Start your investment journey today with Zorion.


Want To Buy Sangamo Therapeutics Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: